Defective & Dangerous Products

Congratulations to Co-lead Counsel Tom Klein and Jason Itkin and the entire plaintiffs’ legal team on a major win against Johnson & Johnson in a…

We have seen this legal question arise before: Should injured plaintiffs be required to provide information about funding they are receiving during the course of…

There is talk of a multibillion-dollar settlement to end the 18,000 lawsuits surrounding the Roundup-cancer connection.

Motley Rice’s achievement last week is the epitome of a “never back down” approach that should inspire us all. After nearly 20 years, the firm…

Journalist Carey Gillian’s 17-year career of covering Monsanto, combined with the Roundup cancer litigation, has brought to light the trust and transparency issues we often see with major corporations.

In case you aren’t already aware, let me be the first to tell you that Fidelma Fitzpatrick, Esq. is a plaintiffs’ superhero. In addition to…

The FDA is updating its requirements to ensure new products “either account for advances in technology or demonstrate that they meet more modern safety and performance criteria.”

The popular heart drug valsartan may have been contaminated with carcinogen NDMA for as long as four years before anyone discovered the problem.

Transvaginal mesh litigation ranks as one of the largest mass tort cases in U.S. history. Trial lawyers have taken mesh manufacturers to task after 100,000…